Fig. 9From: Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinomaSignaling pathway analysis of HM13-mediated effects A GSEA analysis. B Correlation analysis. C Difference analysis. D CHOP expression was significantly reduced after HM13 knockdownBack to article page